🇺🇸 FDA
Patent

US 11166924

N-methyl-d-aspartate receptor allosteric modulators and methods for their use

granted A61KA61K31/165A61K31/166

Quick answer

US patent 11166924 (N-methyl-d-aspartate receptor allosteric modulators and methods for their use) held by Qingdao Primedicine Pharmaceutical Company, Ltd. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Qingdao Primedicine Pharmaceutical Company, Ltd.
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/165, A61K31/166, A61K31/4406, A61K31/4409